MSB Trading 2021 - paradigm shift, page-111

First 111 Last

Share
Profile

Follow
Treed

3,725 Posts.

1276

06/01/21

18:29

Post #: 49988758
Share

Originally posted by Sorepocket: ↑

Thanks for the considered reply. Much better than just droning “where’s your evidence”.

Firstly, yes time will tell. This is just my opinion.

My fundamental problem with MSB and Covid is that I just think it is not cost effective. Yes, the treatment may shorten hospital stay. So assuming MSB does shorten hospital time, a saving, even if you include the expensive treatment. But the real problem is that you have to start the treatment early otherwise it is not effective. This means you must treat people (with the expensive treatments) before they become really sick. And we don’t know who will become really sick.

This means you have to treat people who will not become really sick. This is where it doesn’t work. Because you have to treat loads of people at high cost and the savings only occur if you shorten hospital stay for the very few who would have needed lengthy hospital treatment.

Better returns for your medical spend with other treatments which are cheep and proven.

Expand

Putting the onus on the existing medications and treatments used pre and in ICU - what price do you put on the time expended and also the failure of the existing treatments to save lives. This is where pharmaeconomics comes in, where a price is routinely put on life and medications, outside of triage.

What you might like to believe is expensive can in fact provide a cost saving or other highly prized benefit for national health systems and insurers.

Last edited by Treed: 06/01/21

MSB Price at posting: $2.26 Sentiment: Buy Disclosure: Held
13 Upvote

0 Great analysis

Reply